Search

Search Results

• Pharmacoeconomic Analysis of CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemias

  Irina Vladimirovna Gribkova, A.A. Zavyalov

  205-212

  01.04.2022

• Pharmacoeconomic Analysis of Gilteritinib in the Therapy of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Mutation

  A.S. Kolbin, Yuliya Mikhailovna Gomon, Yu.E. Balykina, M.A. Proskurin

  85-96

  01.01.2022

• Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

  Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva

  321-332

  01.07.2021

• Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

  Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian

  363-376

  01.10.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy

  Vasilii Anatol’evich Shuvaev, S.V. Voloshin, A.K. Hadzhidis, A.V. Chechetkin

  435-442

  01.10.2017

• First Line Treatment Choice for Chronic Myelogenous Leukemia: Modeling of Clinical and Economic Factors

  Vasilii Anatol’evich Shuvaev, K.M. Abdulkadyrov, I.S. Martynkevich, M.S. Fominykh

  78–83

  01.01.2015